EGFR and ovarian carcinoma: The transactivation of EGFR through other G-protein coupled receptors (GPCR) is an important signaling pathway for the induction of both mitogenic and motogenic effects, suggesting a mechanism for the proliferative effects of PAF in ovarian cancer cells.